Karen L. Mansfield, Insiyah Parekh, Thomas Bruun Rasmussen, Louise Lohse, Ann Sofie Olesen, Nolwenn M. Dheilly, Gaëlle Gonzalez, Camille Victoire Migné, Mathilde Gondard, Teheipuaura Helle, Tobias Lilja, Johanna F. Lindahl, Wim H. M. van der Poel, Frank Harders, Gebbiena M. Bron, Melle Holwerda
{"title":"European Preparedness for Japanese Encephalitis Virus Through Alignment of Animal Health Laboratory Diagnosis","authors":"Karen L. Mansfield, Insiyah Parekh, Thomas Bruun Rasmussen, Louise Lohse, Ann Sofie Olesen, Nolwenn M. Dheilly, Gaëlle Gonzalez, Camille Victoire Migné, Mathilde Gondard, Teheipuaura Helle, Tobias Lilja, Johanna F. Lindahl, Wim H. M. van der Poel, Frank Harders, Gebbiena M. Bron, Melle Holwerda","doi":"10.1155/tbed/5516160","DOIUrl":null,"url":null,"abstract":"<div>\n <p>Outbreaks of Japanese encephalitis (JE) can have severe health and economic impacts in both humans and susceptible animal species and are estimated to cause ~68,000 human disease cases in Asia annually. The disease is caused by infection with the mosquito-borne JE virus (JEV), which continues to expand its geographical range from its endemic region in Asia. Since appropriate vertebrate host and mosquito vector species are present in Europe and average European summer temperatures continue to increase, JEV introduction could lead to the establishment of the pathogen in native mosquito species and wild birds and disease outbreaks among humans, pigs, and horses. Incursions could occur through movements of infected pigs and mosquitoes but also via migratory birds that act as reservoirs. Introduction and establishment of JEV in these populations may not be apparent at first, providing time for virus spread before spillover to the human population. Further complicating serological detection of JEV is the extensive cross-reactivity with other orthoflaviviruses circulating in Europe (i.e., tick-borne encephalitis virus [TBEV], West Nile virus [WNV], and Usutu virus [USUV]). In addition, viremia in clinical cases may be short, hindering virus detection. To facilitate European preparedness for detection, surveillance, and monitoring of JEV introduction and spread, five veterinary national reference laboratories in Europe collaborated with the aim to align JEV diagnostic pipelines to prepare for future emergence of JEV in Europe. All institutes assessed established and newly developed serological and molecular assays to build capability with sensitive and specific diagnostic tools for JEV detection. Additionally, methods for whole-genome sequencing (WGS) were established and compared. In summary, this project provides a framework for communication and international collaboration between arboviral researchers at national veterinary institutes. The sharing of knowledge and expertise, and alignment of diagnostic techniques, has facilitated improvement of diagnostic pipelines for JEV detection and contributed to preparedness for JEV introduction into Europe.</p>\n </div>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/5516160","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/5516160","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Outbreaks of Japanese encephalitis (JE) can have severe health and economic impacts in both humans and susceptible animal species and are estimated to cause ~68,000 human disease cases in Asia annually. The disease is caused by infection with the mosquito-borne JE virus (JEV), which continues to expand its geographical range from its endemic region in Asia. Since appropriate vertebrate host and mosquito vector species are present in Europe and average European summer temperatures continue to increase, JEV introduction could lead to the establishment of the pathogen in native mosquito species and wild birds and disease outbreaks among humans, pigs, and horses. Incursions could occur through movements of infected pigs and mosquitoes but also via migratory birds that act as reservoirs. Introduction and establishment of JEV in these populations may not be apparent at first, providing time for virus spread before spillover to the human population. Further complicating serological detection of JEV is the extensive cross-reactivity with other orthoflaviviruses circulating in Europe (i.e., tick-borne encephalitis virus [TBEV], West Nile virus [WNV], and Usutu virus [USUV]). In addition, viremia in clinical cases may be short, hindering virus detection. To facilitate European preparedness for detection, surveillance, and monitoring of JEV introduction and spread, five veterinary national reference laboratories in Europe collaborated with the aim to align JEV diagnostic pipelines to prepare for future emergence of JEV in Europe. All institutes assessed established and newly developed serological and molecular assays to build capability with sensitive and specific diagnostic tools for JEV detection. Additionally, methods for whole-genome sequencing (WGS) were established and compared. In summary, this project provides a framework for communication and international collaboration between arboviral researchers at national veterinary institutes. The sharing of knowledge and expertise, and alignment of diagnostic techniques, has facilitated improvement of diagnostic pipelines for JEV detection and contributed to preparedness for JEV introduction into Europe.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.